Literature DB >> 24608735

Incidence of conversion to active waitlist status among temporarily inactive obese renal transplant candidates.

Edmund Huang1, Michael Shye, David Elashoff, Alireza Mehrnia, Suphamai Bunnapradist.   

Abstract

BACKGROUND: Candidates may be active or temporarily inactive (status 7) on the kidney transplant waiting list. One reason candidates may be inactive is for a "weight currently inappropriate for transplantation." We hypothesized that many of these candidates would not achieve active status.
METHODS: Using OPTN/UNOS data from 2006 to 2012, we used competing risks methods to determine the cumulative incidence of conversion to active status (activation), death, and delisting before conversion among 1679 obese adult kidney candidates designated as status 7 because of a weight inappropriate for transplantation. Fine and Gray competing risks regression was performed to characterize factors associated with conversion to active status in the overall study population and of transplantation among a subgroup of activated candidates.
RESULTS: At 6 years, the cumulative incidence of activation was 49%, of death before conversion was 15%, and of delisting was 21%. Higher body mass index (BMI) was strongly associated with a decreased subhazard of activation (BMI ≥45 versus 30-34.9, sHR: 0.22; 95% CI, 0.16-0.33). Female sex, diabetic end-stage renal disease, history of a previous transplant, panel reactive antibodies less than 80%, dialysis dependence at listing, and UNOS region 5 were negatively associated with activation. Among activated candidates, the cumulative incidence of transplantation at 6 years after initial waitlisting was 61%.
CONCLUSION: Our findings indicate that half of obese status 7 candidates with a weight inappropriate for transplantation will not achieve active waitlist status. BMI at listing had a strong association with conversion to active status; comorbid factors and regional variation also impact activation.

Entities:  

Mesh:

Year:  2014        PMID: 24608735     DOI: 10.1097/TP.0000000000000037

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Kidney Transplant Evaluation: Inferences from Qualitative Interviews with African American Patients and their Providers.

Authors:  Natalia Crenesse-Cozien; Beth Dolph; Meriem Said; Thomas H Feeley; Liise K Kayler
Journal:  J Racial Ethn Health Disparities       Date:  2019-04-24

2.  How patients choose kidney transplant centers: A qualitative study of patient experiences.

Authors:  Cory R Schaffhausen; Marilyn J Bruin; Warren T McKinney; Jon J Snyder; Arthur J Matas; Bertram L Kasiske; Ajay K Israni
Journal:  Clin Transplant       Date:  2019-04-21       Impact factor: 2.863

Review 3.  Obesity Management in Kidney Transplant Candidates: Current Paradigms and Gaps in Knowledge.

Authors:  Joanna H Lee; Elysia O McDonald; Meera N Harhay
Journal:  Adv Chronic Kidney Dis       Date:  2021-11       Impact factor: 3.620

Review 4.  Metabolic Disorders with Kidney Transplant.

Authors:  Elizabeth Cohen; Maria Korah; Glenda Callender; Renata Belfort de Aguiar; Danielle Haakinson
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-13       Impact factor: 8.237

5.  Effects of body mass index on kidney transplant outcomes are significantly modified by patient characteristics.

Authors:  Jesse D Schold; Joshua J Augustine; Anne M Huml; Richard Fatica; Saul Nurko; Alvin Wee; Emilio D Poggio
Journal:  Am J Transplant       Date:  2020-08-27       Impact factor: 8.086

6.  Linguistic Isolation and Access to the Active Kidney Transplant Waiting List in the United States.

Authors:  Efrain Talamantes; Keith C Norris; Carol M Mangione; Gerardo Moreno; Amy D Waterman; John D Peipert; Suphamai Bunnapradist; Edmund Huang
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-09       Impact factor: 10.614

7.  Type 2 diabetic patients on renal replacement therapy: Probability to receive renal transplantation and survival after transplantation.

Authors:  Marjo H Kervinen; Seppo Lehto; Jaakko Helve; Carola Grönhagen-Riska; Patrik Finne
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.